Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05498155 |
|---|---|
| Brief Title: | Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer (OlympiaN) |
| First Submitted : | July 5, 2022 |
| First Submitted that Met QC Criteria : | August 10, 2022 |
| First Posted : | August 11, 2022 |
| Last Update Submitted that Met QC Criteria : | May 8, 2024 |
| Last Update Posted : | May 9, 2024 |